Aegle Therapeutics CEO Shelley A. Hartman joined BioWorld and other biopharma executives to discuss 2023 challenges and opportunities for the year ahead. Check out the insightful podcast! https://lnkd.in/eg48P8yz
Aegle Therapeutics’ Post
More Relevant Posts
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/ITpu50Sm11S In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
To view or add a comment, sign in
-
Adiso is keeping #patientsfirst by working to shape a brighter future free from the burden of inflammatory disease. Listen to our recent conversation with Rahul Chaturvedi of the Biotech2050 podcast. https://t.ly/lF_JG #Leadership #IBD #ulcerativecolitis
Are you prepared to explore the realm of biotech innovations and evolving industry dynamics? Join host Rahul Chaturvedi in the latest episode of the Biotech2050 podcast with Scott Megaffin, CEO of Adiso Therapeutics, as they discuss differentiation and collaboration in the biotech industry Listen to the episode: https://t.ly/lF_JG
To view or add a comment, sign in
-
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/L9Jp50SiuBf In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
Podcast: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
scrip.citeline.com
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/1lb850SFXez In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
Podcast: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
scrip.citeline.com
To view or add a comment, sign in
-
New week and that means a new episode of "Måndagsaktier" is out 📈 This week we talked about the current financial situation but also made an analysis and compared Novo Nordisk and Astra Zeneca 💊 Two scandinavian giants who is undoubtedly essential for our global pharmaceutical development! I also wanted to let you know that i'm joining the Feminvest podcast this week! Talking Life Science, Birkenstock & Rusta IPO together with Michaela Berglund 🎙 Tune in and listen to my podcast debut! #feminvest #lifescience #acceleratefemaleownership #podcast
To view or add a comment, sign in
-
-
🔍 Discover how Alisa joined the world of biologics, which is very different from her experiences in emergency management. In Episode 26 of That's Derm Good!, Alisa Redmon explains how treatments impact your patients' lives and the satisfaction of visually seeing changes in your patients skin. Listen wherever you find your favorite podcasts!
To view or add a comment, sign in
-
🎧 In the newest episode of Molecule to Market, Raman Sehgal is joined by Bruce Thompson, CEO of Kincell Bio. Together, they discuss: 👉 The daunting and exciting prospect of launching a CDMO spin-out focused on early-phase companies 👉 The challenges and opportunities of pivoting a facility from innovator-owned to CDMO-owned 👉 Navigating from technical leader to a first CEO role…and the importance of covering your blind spots Listen below, you don't want to miss it! #PharmaPodcast #CDMO #Podcast
Launching a technology-forward CDMO - Molecule to Market
https://moleculetomarketpod.com
To view or add a comment, sign in
-
LISTEN NOW: In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, A. J. Loiacono, share the story behind the strategic alliance between their organizations and their vision to reimagine pharmacy. “We knew that platform modernization was going to be an important priority for us,” Kamal said. “And when we stacked the options, everything that’s available externally, internal build, it was a no brainer that the right partner for us was Capital Rx. When you think about the capabilities, the alignment around vision and mission and key principles, and it also helps that there’s a level of trust in our relationship as well.” Read more and listen to the full episode here: https://bit.ly/3TGWvPU
To view or add a comment, sign in
-
-
Thank you, Citeline Commercial, for your podcast interviewing our CEO and Co-Founder, Joel Morse, as well as our partners, Andy Molnar, CEO of Digital Therapeutics Alliance, and Owen McCarthy, CEO of MedRhythms, Inc.! Give the podcast a listen to hear the trio discuss the current situation surrounding #digitaltherapeutics, and where they believe they are headed in the coming years. #DTx #clinicalresearch #DCTs https://lnkd.in/gErsWZvJ
Podcast: Discussing The Potentials Of And Challenges For Digital Therapeutics
medtech.citeline.com
To view or add a comment, sign in
-
Chief Medical Officers from biotech companies Xalud Therapeutics, Inc., SparingVision, Altimmune, Inc.and Zai Lab joined us at the CMO Summit 360º in April to explain how they pitch to different investors and how their pitching methodology has evolved over time. Learn more valuable insights and lessons through this podcast. Listen to the podcast here: https://lnkd.in/gPNs6FmM #CMO #CMO360
To view or add a comment, sign in
-